ANDREW C. PHILLIPS,ANDREW J. SOUERS,ANDREW S. JUDD,ERWIN R. BOGHAERT,MILAN BRUNCKO
申请号：
BR112018075645
公开号：
BR112018075645A2
申请日:
2017.06.07
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
The invention refers to a combination of drug antibodies (cafs) that inhibit bcl -xl, including compositions and methods of use of said cafes.a invenção se refere a conjugados anticorpo fármaco (cafs) anti-receptor do fator de crescimento epidérmico (egfr) que inibem bcl-xl, incluindo composi-ções e métodos de uso dos ditos cafs.
